ArticleCancer medicine2021

First-line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component.

Yu-Wen Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.